BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23923348)

  • 21. False-positive results from a diagnostic colonoscopy: a teachable moment.
    Sheu L; Gottenborg EW
    JAMA Intern Med; 2014 May; 174(5):665-6. PubMed ID: 24663348
    [No Abstract]   [Full Text] [Related]  

  • 22. Irritable Bowel Syndrome in Adults (IBS-D): Clinical Decision Support Tool.
    American Gastroenterological Association
    Gastroenterology; 2019 Sep; 157(3):855. PubMed ID: 31323183
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tests to detect GI motility disorders and GI sensation in irritable bowel syndrome].
    Okumura T
    Nihon Rinsho; 2006 Aug; 64(8):1457-60. PubMed ID: 16898612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome.
    Hod K; Dickman R; Sperber A; Melamed S; Dekel R; Ron Y; Halpern Z; Berliner S; Maharshak N
    Neurogastroenterol Motil; 2011 Dec; 23(12):1105-10. PubMed ID: 21951717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome.
    Christmas DM; Badawy AA; Hince D; Davies SJ; Probert C; Creed T; Smithson J; Afzal M; Nutt DJ; Potokar JP
    Nutr Res; 2010 Oct; 30(10):678-88. PubMed ID: 21056283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irritable bowel syndrome.
    Bolin TD
    Aust Fam Physician; 2005 Apr; 34(4):221-4. PubMed ID: 15861740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart rate variability is related to pain severity and predominant bowel pattern in women with irritable bowel syndrome.
    Cain KC; Jarrett ME; Burr RL; Hertig VL; Heitkemper MM
    Neurogastroenterol Motil; 2007 Feb; 19(2):110-8. PubMed ID: 17244165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
    Crentsil V
    Med Hypotheses; 2005; 65(1):97-102. PubMed ID: 15893125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.
    Dinan TG; Clarke G; Quigley EM; Scott LV; Shanahan F; Cryan J; Cooney J; Keeling PW
    Am J Gastroenterol; 2008 Oct; 103(10):2570-6. PubMed ID: 18785949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome.
    Sadik R; Björnsson E; Simrén M
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):102-8. PubMed ID: 19701093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diarrhea in long-term care: a messy problem.
    Morley JE; Steinberg KE
    J Am Med Dir Assoc; 2009 May; 10(4):213-7. PubMed ID: 19426933
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.
    Suttor VP; Prott GM; Hansen RD; Kellow JE; Malcolm A
    Dis Colon Rectum; 2010 Feb; 53(2):156-60. PubMed ID: 20087090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
    Keohane J; O'Mahony C; O'Mahony L; O'Mahony S; Quigley EM; Shanahan F
    Am J Gastroenterol; 2010 Aug; 105(8):1788, 1789-94; quiz 1795. PubMed ID: 20389294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irritable bowel syndrome: a population based study.
    Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
    Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of lower functional gut disorders.
    Andrews CN; Storr M
    Can J Gastroenterol; 2008 Jul; 22(7):614-6. PubMed ID: 18629389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.